Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Pfizer Limited
Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 12/01/2010
PIL Doxorubicin Rapid Dissolution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12/01/2010 and displayed until Current
Reasons for adding or updating:
  • Change to information for healthcare professionals
Updated on 08/01/2010 and displayed until 12/01/2010
Reasons for adding or updating:
  • Change to information for healthcare professionals
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 14/07/2009 and displayed until 08/01/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 30/01/2009 and displayed until 14/07/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 14/10/2008 and displayed until 30/01/2009
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 15/04/2008 and displayed until 14/10/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 15/02/2008 and displayed until 15/04/2008
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 05/09/2007 and displayed until 15/02/2008
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 11/01/2007 and displayed until 05/09/2007
Reasons for adding or updating:
  • Correction of spelling/typing errors
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to information about pregnancy or lactation
  • Change to date of revision
  • Change to how to administer the medicine
  • Change to dosage and administration
Updated on 17/10/2002 and displayed until 11/01/2007
Reasons for adding or updating:
  • Update to PIL
Updated on 28/07/2000 and displayed until 17/10/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  doxorubicin hydrochloride